1
Home
Companies

PaxMedica

#10526

Rank

$88.39K

Marketcap

US United States

Country

PaxMedica
Leadership team

Mr. Michael L. Derby M.B.A., M.S. (Exec. Chairman)

Mr. Howard J. Weisman (CEO & Director)

Mr. Stephen Douglas Sheldon (Chief Financial Officer)

Products/ Services
Biotechnology, Medical, Pharmaceutical
Headquarters
Tarrytown, New York, United States
Established
2018
Company Registration
SEC CIK number: 0001811623
Traded as
PXMD
Social Media
URL
https://www.paxmedica.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT). It also develops PAX-102, an intranasal formulation of suramin for neurologic indications; and HAT-301 for the treatment of stage 1 East African HAT. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was founded in 2018 and is based in Tarrytown, New York.
History

Pax Medica was founded in 2010 with the mission of providing comprehensive, integrated healthcare solutions. Since then, the company has established itself as a leader in healthcare services and has grown to provide a wide range of services, from patient care and clinical trial services to health analytics and telemedicine. Pax Medica is committed to delivering an unprecedented level of care to all of its clients.

Mission
To improve the health of patients and facilitate the delivery of quality healthcare through integrated, cutting-edge services and innovative solutions.
Vision
Pax Medica's vision is to be the global leader in integrated healthcare services, driving healthcare transformation and setting a new standard of excellence in patient care.
Key Team

Mr. Zachary Rome (COO & Director)

Dr. Stefan K. F. Schwabe M.D., Ph.D. (Chief Medical Officer)

Recognition and Awards
Pax Medica has won numerous awards, including: Health IT Company of the Year , Top Provider of Telehealth Technology , and Innovation in Patient Care .
References

https://in.investing.com/equities/paxmedica-inc-company-profile

https://finance.yahoo.com/quote/PXMD/profile?p=PXMD

https://www.crunchbase.com/organization/paxmedica

https://companiesmarketcap.com/

https://www.paxmedica.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

PaxMedica
Leadership team

Mr. Michael L. Derby M.B.A., M.S. (Exec. Chairman)

Mr. Howard J. Weisman (CEO & Director)

Mr. Stephen Douglas Sheldon (Chief Financial Officer)

Products/ Services
Biotechnology, Medical, Pharmaceutical
Headquarters
Tarrytown, New York, United States
Established
2018
Company Registration
SEC CIK number: 0001811623
Traded as
PXMD
Social Media
URL
https://www.paxmedica.com